3 studies found for:    18506025 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: MK-3475;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Pemetrexed
2 Not yet recruiting A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
Condition: Carcinoma of the Lung.
Interventions: Drug: Binimetinib;   Drug: Pemetrexed;   Drug: Carboplatin
3 Completed Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Interventions: Drug: docetaxel;   Drug: pemetrexed

Indicates status has not been verified in more than two years